Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions

Bert Bier, Anthony Douglas-Jones, Martin Tötsch, Barbara Dockhorn-Dworniczak, Werner Böcker, Bharat Jasani, Kurt Werner Schmid

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Metallothioneins (MTs) are a set of low molecular weight proteins with a high binding affinity to metal ions. MT over-expression has been recently demonstrated in invasive ductal carcinoma of the breast with poor clinical prognosis. In the present study, MTs have been immunohistochemically investigated in normal human breast tissue and a variety of benign, pre-invasive, and malignant breast lesions. In normal breast tissue, MTs were present in myoepithelial cells whereas the vast majority of luminal cells were MT negative. In lesions without increased cancer risk (adenosis and scleradenosis), MT was only immunolocalized in myoepithelial cells. In papillomas, MT was also found exclusively in myoepithelial cells. In most cases of epitheliosis, both the luminal and myoepithelial cells expressed MT. Atypicallobular hyperplasia, lobular carcinoma in situ, and 13/15 invasive lobular carcinomas showed no MT over-expression. The two invasive lobular carcinomas with MT over-expression were classified as pleomorphic lobular carcinomas with apocrine differentiation. In contrast to lobular cancerization, 12/24 ductal in situ carcinomas and 9/20 invasive ductal carcinomas showed MT over-expression. In situ components found within invasive ductal carcinomas usually reflected the MT status of their invasive counterpart. It is concluded from our immunohistochemical results that breast carcinoma cases with MT overexpression arise from lesions which also show MT overexpression. Thus MT expression in carcinomas may be regarded as a genuine feature of the tumour cells and seems not to be related to endogenous or exogenous factors known to induce MT synthesis.

Original languageEnglish
Pages (from-to)213-221
Number of pages9
JournalBreast Cancer Research and Treatment
Volume30
Issue number3
DOIs
Publication statusPublished - Jan 1994
Externally publishedYes

Fingerprint

Metallothionein
Breast
Lobular Carcinoma
Ductal Carcinoma
Carcinoma, Ductal, Breast
Carcinoma, Intraductal, Noninfiltrating
Papilloma
Hyperplasia
Neoplasms
Molecular Weight
Metals
Ions
Breast Neoplasms
Carcinoma
Proteins

Keywords

  • breast carcinoma
  • carcinoma in situ
  • hyperplastic breast lesions
  • immunohistochemistry
  • metallothionein

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Bier, B., Douglas-Jones, A., Tötsch, M., Dockhorn-Dworniczak, B., Böcker, W., Jasani, B., & Schmid, K. W. (1994). Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions. Breast Cancer Research and Treatment, 30(3), 213-221. https://doi.org/10.1007/BF00665963

Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions. / Bier, Bert; Douglas-Jones, Anthony; Tötsch, Martin; Dockhorn-Dworniczak, Barbara; Böcker, Werner; Jasani, Bharat; Schmid, Kurt Werner.

In: Breast Cancer Research and Treatment, Vol. 30, No. 3, 01.1994, p. 213-221.

Research output: Contribution to journalArticle

Bier, B, Douglas-Jones, A, Tötsch, M, Dockhorn-Dworniczak, B, Böcker, W, Jasani, B & Schmid, KW 1994, 'Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions', Breast Cancer Research and Treatment, vol. 30, no. 3, pp. 213-221. https://doi.org/10.1007/BF00665963
Bier, Bert ; Douglas-Jones, Anthony ; Tötsch, Martin ; Dockhorn-Dworniczak, Barbara ; Böcker, Werner ; Jasani, Bharat ; Schmid, Kurt Werner. / Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions. In: Breast Cancer Research and Treatment. 1994 ; Vol. 30, No. 3. pp. 213-221.
@article{bcc85feeb2e44d56a43f8acef5633355,
title = "Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions",
abstract = "Metallothioneins (MTs) are a set of low molecular weight proteins with a high binding affinity to metal ions. MT over-expression has been recently demonstrated in invasive ductal carcinoma of the breast with poor clinical prognosis. In the present study, MTs have been immunohistochemically investigated in normal human breast tissue and a variety of benign, pre-invasive, and malignant breast lesions. In normal breast tissue, MTs were present in myoepithelial cells whereas the vast majority of luminal cells were MT negative. In lesions without increased cancer risk (adenosis and scleradenosis), MT was only immunolocalized in myoepithelial cells. In papillomas, MT was also found exclusively in myoepithelial cells. In most cases of epitheliosis, both the luminal and myoepithelial cells expressed MT. Atypicallobular hyperplasia, lobular carcinoma in situ, and 13/15 invasive lobular carcinomas showed no MT over-expression. The two invasive lobular carcinomas with MT over-expression were classified as pleomorphic lobular carcinomas with apocrine differentiation. In contrast to lobular cancerization, 12/24 ductal in situ carcinomas and 9/20 invasive ductal carcinomas showed MT over-expression. In situ components found within invasive ductal carcinomas usually reflected the MT status of their invasive counterpart. It is concluded from our immunohistochemical results that breast carcinoma cases with MT overexpression arise from lesions which also show MT overexpression. Thus MT expression in carcinomas may be regarded as a genuine feature of the tumour cells and seems not to be related to endogenous or exogenous factors known to induce MT synthesis.",
keywords = "breast carcinoma, carcinoma in situ, hyperplastic breast lesions, immunohistochemistry, metallothionein",
author = "Bert Bier and Anthony Douglas-Jones and Martin T{\"o}tsch and Barbara Dockhorn-Dworniczak and Werner B{\"o}cker and Bharat Jasani and Schmid, {Kurt Werner}",
year = "1994",
month = "1",
doi = "10.1007/BF00665963",
language = "English",
volume = "30",
pages = "213--221",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions

AU - Bier, Bert

AU - Douglas-Jones, Anthony

AU - Tötsch, Martin

AU - Dockhorn-Dworniczak, Barbara

AU - Böcker, Werner

AU - Jasani, Bharat

AU - Schmid, Kurt Werner

PY - 1994/1

Y1 - 1994/1

N2 - Metallothioneins (MTs) are a set of low molecular weight proteins with a high binding affinity to metal ions. MT over-expression has been recently demonstrated in invasive ductal carcinoma of the breast with poor clinical prognosis. In the present study, MTs have been immunohistochemically investigated in normal human breast tissue and a variety of benign, pre-invasive, and malignant breast lesions. In normal breast tissue, MTs were present in myoepithelial cells whereas the vast majority of luminal cells were MT negative. In lesions without increased cancer risk (adenosis and scleradenosis), MT was only immunolocalized in myoepithelial cells. In papillomas, MT was also found exclusively in myoepithelial cells. In most cases of epitheliosis, both the luminal and myoepithelial cells expressed MT. Atypicallobular hyperplasia, lobular carcinoma in situ, and 13/15 invasive lobular carcinomas showed no MT over-expression. The two invasive lobular carcinomas with MT over-expression were classified as pleomorphic lobular carcinomas with apocrine differentiation. In contrast to lobular cancerization, 12/24 ductal in situ carcinomas and 9/20 invasive ductal carcinomas showed MT over-expression. In situ components found within invasive ductal carcinomas usually reflected the MT status of their invasive counterpart. It is concluded from our immunohistochemical results that breast carcinoma cases with MT overexpression arise from lesions which also show MT overexpression. Thus MT expression in carcinomas may be regarded as a genuine feature of the tumour cells and seems not to be related to endogenous or exogenous factors known to induce MT synthesis.

AB - Metallothioneins (MTs) are a set of low molecular weight proteins with a high binding affinity to metal ions. MT over-expression has been recently demonstrated in invasive ductal carcinoma of the breast with poor clinical prognosis. In the present study, MTs have been immunohistochemically investigated in normal human breast tissue and a variety of benign, pre-invasive, and malignant breast lesions. In normal breast tissue, MTs were present in myoepithelial cells whereas the vast majority of luminal cells were MT negative. In lesions without increased cancer risk (adenosis and scleradenosis), MT was only immunolocalized in myoepithelial cells. In papillomas, MT was also found exclusively in myoepithelial cells. In most cases of epitheliosis, both the luminal and myoepithelial cells expressed MT. Atypicallobular hyperplasia, lobular carcinoma in situ, and 13/15 invasive lobular carcinomas showed no MT over-expression. The two invasive lobular carcinomas with MT over-expression were classified as pleomorphic lobular carcinomas with apocrine differentiation. In contrast to lobular cancerization, 12/24 ductal in situ carcinomas and 9/20 invasive ductal carcinomas showed MT over-expression. In situ components found within invasive ductal carcinomas usually reflected the MT status of their invasive counterpart. It is concluded from our immunohistochemical results that breast carcinoma cases with MT overexpression arise from lesions which also show MT overexpression. Thus MT expression in carcinomas may be regarded as a genuine feature of the tumour cells and seems not to be related to endogenous or exogenous factors known to induce MT synthesis.

KW - breast carcinoma

KW - carcinoma in situ

KW - hyperplastic breast lesions

KW - immunohistochemistry

KW - metallothionein

UR - http://www.scopus.com/inward/record.url?scp=0028064532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028064532&partnerID=8YFLogxK

U2 - 10.1007/BF00665963

DO - 10.1007/BF00665963

M3 - Article

VL - 30

SP - 213

EP - 221

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -